Abstract For this paper, two scenarios will be examined. One, a pharmaceutical company, which has come under investigation by the Federal Trade Commission to determine whether the company has engaged in illegal activities to keep a generic drug off the market. The other, two large telecommunications companies have agreed to merge, and consumer advocates are very concerned with the possible outcome of this merger. The effects of both companies’ actions on competition will be examined
Words: 1757 - Pages: 8
v. Mensing Doctors prescribed both Gladys Mensing and Julie Demahy the drug Reglan. They each had their prescriptions filled with the generic equivalent of the name brand drug. After long-term use of this generic drug, Mensing and Demahy developed severe neurologic disorders. The women separately sued Pliva and Actavis, the generic drug manufacturers, making state law failure-to-warn claims, alleging that the drug’s warning label failed to adequately warn them of the risks. Pliva
Words: 845 - Pages: 4
It accounts for about 1.4% of the world's pharma industry in value terms and 10% in volume terms. Besides the domestic market, Indian pharma companies also have a large chunk of their revenues coming from exports. While some are focusing on the generics market in the US, Europe and semi-regulated markets, others are focusing on custom manufacturing for innovator companies. Biopharmaceuticals is also increasingly becoming an area of interest given the complexity in manufacture and limited competition
Words: 1721 - Pages: 7
PHARMACEUTICAL PRODUCTS, THE INTRODUCTION OF COMPETING GENERIC EQUIVALENTS, THE EXTENT TO WHICH TEVA MAY OBTAIN U.S. MARKET EXCLUSIVITY FOR CERTAIN OF ITS NEW GENERIC PRODUCTS AND REGULATORY CHANGES THAT MAY PREVENT TEVA FROM UTILIZING EXCLUSIVITY PERIODS, COMPETITION FROM BRAND-NAME COMPANIES THAT ARE UNDER INCREASED PRESSURE TO COUNTER GENERIC PRODUCTS, OR COMPETITORS THAT SEEK TO DELAY THE INTRODUCTION OF GENERIC PRODUCTS, POTENTIAL LIABILITY FOR SALES OF GENERIC PRODUCTS PRIOR TO A FINAL RESOLUTION OF OUTSTANDING
Words: 7679 - Pages: 31
Generic drugs are copies of brand-name drugs that have exactly the same dosage, intended use, effects, sideeffects, and route of administration, risks, safety, and strength as the original drug. In other words, their pharmacological effects are exactly the same as those of their brand-name counterparts. Many people become concerned because generic drugs are often substantially cheaper than the brand-name versions. They wonder if the quality and effectiveness have been compromised to make
Words: 1583 - Pages: 7
Intellectual Property Rights and the Pharmaceutical Industry Patented medicines are not to blame for lack of access to life-saving drugs Two bottles of a medicine Two bottles of a medicine for liver patients, Epogen, one real (left) and one counterfeit. (© AP Images) (The following article is taken from the U.S. Department of State publication, Focus on Intellectual Property Rights.) Intellectual Property Rights and the Pharmaceutical Industry By Judith Kaufmann Many claim that
Words: 1234 - Pages: 5
in Kava could be a great opportunity for the Teva Pharmaceuticals to expand its mission which is “to play a leading role in the transformation of the U.S. healthcare system through its pre-eminence in the development, manufacture and marketing of generic pharmaceuticals (TEVA USA., 2010, para 2)”. The company can expand that mission to the healthcare system of Kava Island highly vulnerable to many threats particularly storm, tsunami, earthquake, flood, fire, petroleum spills, AIDS/HIV, and avian flu
Words: 1991 - Pages: 8
INTRODUCTION The 1990’s saw a highly fragmented pharmaceutical industry with many competitors. The top ten firms in pharmaceutical sales held 28% market share in mid-1995. The top 50 firms held just over 60 percent. Changes were occurring in the pharmaceutical industry in the 1990’s. With pharmaceutical benefit management (PBM) firms working to reduce costs, pharmaceutical firms held less power. PBMs sought to reduce the number of supplier firms by only purchasing from the largest firms and requiring
Words: 1695 - Pages: 7
impacted sub-saharan LDC’s access to health care? VI. What individual examples exist of TRIPS positively and negatively impacting sub-saharan welfare? VII. Which countries express the greatest need for generic pharmaceuticals? VIII. What are the real effects on pharmaceutical companies when generic medications are sold IX. How does TRIPS effect R&D in LDC’s? International Studies 100 Hill 1 Brendan Hill | 200245349 November, 14, 2014 Aspects of Globalization This essay will conduct
Words: 481 - Pages: 2
I. FARMACEUTICAL INDUSTRY OVERVIEW 1. Major players of the world pharmaceutical industry ( and some numbers) The pharmaceutical industry is characterized by a high level of concentration with 15 multinational companies dominating the industry. http://www.pmlive.com/top_pharma_list/global_revenues The majority of the largest pharmaceutical companies are not diversified. They are either concentrated exclusively on pharmaceutical products (Eli Lilly and AstraZeneca are good examples with
Words: 836 - Pages: 4
